Renasant Bio

Berkeley, CA · Founded 2022 · Privately Held (backing)

Operator of a biopharmaceutical research platform intended to develop oral small-molecule therapies for genetic kidney disorders. Renasant Bio is based in Berkeley, CA and was founded in 2022. It was valued at $78 million at its seed round in Jun 2025, the last priced event on record. It has raised $55.5 million across 2 recorded rounds; the latest was a $30 million early-stage round in Jun 2025.

PMV mark · valuation
$78.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$55.5M
Last round
Early Stage VC
Jun 2025
What is Renasant Bio worth?
$78.0MPrivateMarketView mark · Oct 2026

Valued at $78.0M at its seed round, Jun 2025. Nothing has traded since.

Free account
More of Renasant Bio with a free account
  • ·Watch Renasant Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Renasant Bio funding history

2 rounds
DateRoundRaisedPost-money
Jun 2025Early Stage VC$30.0M▮
Jul 2024Early Stage VC$25.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Renasant Bio valuation

Renasant Bio was valued at $78 million at its seed round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Renasant Bio raised?

Renasant Bio has raised $55.5 million across 2 recorded rounds since 2024. The largest was a $30 million early-stage round in Jun 2025.

Renasant Bio has filed 2 Form Ds with the SEC, most recently in Jul 2025 ($25.5 million sold to 3 investors).

How Renasant Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Renasant Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Renasant Bio

What is Renasant Bio worth?
Renasant Bio is valued at $78.0M as of Oct 2026. Valued at $78.0M at its seed round, Jun 2025. Nothing has traded since.
How much has Renasant Bio raised?
Renasant Bio has raised $55.5M in total funding across 2 recorded rounds.
When did Renasant Bio last raise?
Renasant Bio last raised in Jun 2025 (Early Stage VC), raising $30.0M.